Author:
Hammond Emmanuel NiiBoye,Vangu Mboyo-Di-Tamba Heben Willy
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine
Reference20 articles.
1. Allahabadia A, Daykin J, Sheppard MC, Gough SC, Franklyn JA. Radioiodine treatment of hyperthyroidism – prognostic factors for outcome. J Clin Endocrinol Metab. 2001;86(8):3611–7.
2. Jameson JL, Weetman AP. Diseases of the thyroid gland. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, editors. Harrison’s principles of internal medicine. 16th ed. London: McGraw Hill; 2005. p. 2104–26.
3. Nordyke RA, Gilbert Jr FI. Optimal Iodine-131 dose for eliminating hyperthyroidism in Graves’ disease. J Nucl Med. 1991;32:411–6.
4. Santos RB, Romaldini JH, Ward LS. Propylthiouracil reduces the effectiveness of radioiodine treatment in hyperthyroid patients with Graves' disease. Thyroid. 2004;14(7):525–30. doi: 10.1089/1050725041517093 .
5. Vijayakumar V, Ali S, Nishino T, Nusynowitz M. What influences early hypothyroidism after radioiodine treatment for Graves’ hyperthyroidism? Clin Nucl Med. 2006;31(11):688–9. doi: 10.1097/01.rlu.0000242213.26839.20 .
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献